Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 99.39% is 133% above its 3-year average of 42.69%, near the high end of its 3-year range (0.00%–100.00%).
0.16% below its 12-month average of 99.55%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
99.39%
GROSS MARGIN AVG TTM
99.55%
GROSS MARGIN AVG 3Y
45.98%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.16%
CURRENT VS 3Y AVG
+116.16%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+141.21%
vs the sector median at left
Market Cap
$235.97M
Gross Margin
68.57%
TTM Avg
73.00%
3Y Avg
80.96%
5Y Avg
81.80%
Market Cap
$235.66M
Gross Margin
79.48%
TTM Avg
71.93%
3Y Avg
74.52%
5Y Avg
72.98%
Market Cap
$235.08M
Gross Margin
54.88%
TTM Avg
55.31%
3Y Avg
58.01%
5Y Avg
59.27%
Market Cap
$239.02M
Gross Margin
88.00%
TTM Avg
94.00%
3Y Avg
97.00%
5Y Avg
64.67%
Market Cap
$232.72M
Gross Margin
-24677.94%
TTM Avg
-13289.35%
3Y Avg
-6830.59%
5Y Avg
-4553.73%
Market Cap
$241.34M
Gross Margin
47.33%
TTM Avg
49.83%
3Y Avg
36.19%
5Y Avg
24.13%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $236.82M | 99.39% | 99.55% | 45.98% | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 91.35% | 93.31% | 46.66% | 31.10% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 68.57% | 73.00% | 80.96% | 81.80% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 79.48% | 71.93% | 74.52% | 72.98% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 54.88% | 55.31% | 58.01% | 59.27% |
| High Tide Inc. (HITI)vs › | $239.01M | 25.85% | 26.57% | 27.09% | 30.11% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 88.00% | 94.00% | 97.00% | 64.67% |
| InflaRx N.V. (IFRX)vs › | $232.72M | -24677.94% | -13289.35% | -6830.59% | -4553.73% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | 47.33% | 49.83% | 36.19% | 24.13% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 99.84% | 50.00% | 75.00% | 50.00% |
Gross Margin
99.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 97.73% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
